The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Hepatitis B and hepatocellular carcinoma #
Open accessAbstract
Chronic infection with the hepatitis B virus has been linked epidemiologically to the development of hepatocellular carcinoma for more than 30 years. Although the mechanisms by which chronic hepatitis B viral infection results in hepatocellular carcinoma are unclear, there is good evidence that the virus itself exerts a direct hepatocarcinogenic effect, and this has implications for prevention. First, programs of universal infant vaccination have been shown to be effective in reducing the rate of hepatocellular carcinoma among children. This benefit should be translated into adulthood among vaccine recipients. Second, it has been suggested that antiviral therapy against hepatitis B may reduce the risk of hepatocellular carcinoma. Antiviral therapy against hepatitis B is effective in causing prolonged lowering of serum levels of hepatitis B virus DNA. There are emerging data showing that prolonged antiviral therapy may reduce the risk of hepatocellular carcinoma among certain patients with chronic hepatitis B. (Hepatology 200949:S56–S60.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Estimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Lu, S.-N., Liaw, Y.-F., You, S.-L., Sun, C.-A., Wang, L.-Y., Hsiao, C. K., Chen, P.-J., Chen, D.-S., & Chen, C.-J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,222
McMahon, B. J., Bulkow, L., Harpster, A., Snowball, M., Lanier, A., Sacco, F., Dunaway, E., & Williams, J. (2000) · Hepatology · doi:10.1053/jhep.2000.17914 · Cited by 327
Natural history of chronic HBV carriers in northern Italy: Morbidity and mortality after 30 years
Manno, M., Cammà, C., Schepis, F., Bassi, F., Gelmini, R., Giannini, F., Miselli, F., Grottola, A., Ferretti, I., Vecchi, C., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.021 · Cited by 256
Sherlock, S., Niazi, S. P., Fox, R. A., & Scheuer, P. J. (1970) · The Lancet · doi:10.1016/s0140-6736(70)91737-x · Cited by 252
Livingston, S. E., Simonetti, J. P., McMahon, B. J., Bulkow, L. R., Hurlburt, K. J., Homan, C. E., Snowball, M. M., Cagle, H. H., Williams, J. L., & Chulanov, V. P. (2007) · The Journal of Infectious Diseases · doi:10.1086/509894 · Cited by 241
Evans, A. A., Chen, G., Ross, E. A., Shen, F., Lin, W., & London, W. T. (2002) · PubMed · Cited by 208
Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status
Di Bisceglie, A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00552-5 · Cited by 189
Self-citationMOLECULAR EVENTS IN THE PATHOGENESIS OF HEPADNAVIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA
Robinson, M. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.297 · Cited by 175
Chang, M.-H., Chen, T. H.-H., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Ni, Y.-H., Chen, C.-J., Chen, D.-S., & for the Taiwan Childhood HCC Study Group (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1095 · Cited by 159
Tang, B., Kruger, W. D., Chen, G., Shen, F., Lin, W. Y., Mboup, S., London, W. T., & Evans, A. A. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10559 · Cited by 88
Muroyama, R., Kato, N., Yoshida, H., Otsuka, M., Moriyama, M., Wang, Y., Shao, R., Dharel, N., Tanaka, Y., Ohta, M., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.07.025 · Cited by 71
Epidermal growth factor and related molecules.
Waterfield, M. D. (1989) · The Lancet · Cited by 57
Viral pathogenesis of hepatocellular carcinoma
Blum, H. E., & Moradpour, D. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s3.37.x · Cited by 36
Hepatitis‐B virus infection in black children with hepatocellular carcinoma
Kew, M. C., Hodkinson, J., Paterson, A. C., & Song, E. H. (1982) · Journal of Medical Virology · doi:10.1002/jmv.1890090307 · Cited by 22
Cited by
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Mechanisms of HBV-induced hepatocellular carcinoma
Levrero, M., & Zucman-Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,052
Immunobiology and pathogenesis of hepatitis B virus infection
Iannacone, M., & Guidotti, L. G. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00549-4 · Cited by 520
Clocchiatti, A., Cora, E., Zhang, Y., & Dotto, G. P. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.30 · Cited by 374
Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent Advancements
Hoshida, Y., Toffanin, S., Lachenmayer, A., Villanueva, A., Minguez, B., & Llovet, J. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247131 · Cited by 310
Metadata
- Authors
- Di Bisceglie, A. M.
- Venue
- Hepatology
- Published
- 2009-05
- Volume
- 49
- Issue
- Suppl. 5
- Pages
- S56-S60
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2126216210
- Cited by
- 321
- References
- 22
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.